发明名称 |
Variante de factor 21 de crecimiento de fibroblasto humano (fgf21); composicion farmaceutica que lo comprende; y su uso para tratar diabetes tipo 2, obesidad, dislipidemia, sindrome metabolico o cualquier combinacion de los mismos. |
摘要 |
This present invention relates to pharmacologically potent and/or stable variants of human fibroblast growth factor 21 (FGF21), pharmaceutical compositions comprising FGF21 variants, and methods for treating type 2 diabetes, obesity, dyslipidemia, or metabolic syndrome, or any combination thereof, using such variants. |
申请公布号 |
CL2014000801(A1) |
申请公布日期 |
2014.09.12 |
申请号 |
CL20140000801 |
申请日期 |
2014.04.02 |
申请人 |
ELI LILLY AND COMPANY |
发明人 |
DICKINSON, CRAIG, DUANE;DRIVER, DAVID, ALBERT;DARLING, RYAN, JAMES;GONCIARZ, MALGORZATA, DONATA;MICANOVIC, RADMILA |
分类号 |
C07K14/50;A61K38/18;A61P3/00 |
主分类号 |
C07K14/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|